AI and Epigenetics: A New Opportunity for Early Pancreatic Cancer Detection in Australia
Open Access
- 14 July 2026
- journal article
- perspective
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (9) , 2267-2269
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Emerging landscape of KRAS inhibitors in cancer treatmentCancer Cell, 2026
- Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational studyThe Lancet Oncology, 2025
- Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the futureCA: A Cancer Journal for Clinicians, 2025
- Artificial Intelligence in Pancreatic Imaging: A Systematic ReviewUnited European Gastroenterology Journal, 2025
- Analytical Validation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation SignaturesThe Journal of Molecular Diagnostics, 2024
- Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patientsThe Lancet Oncology, 2024
- Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNAClinical Gastroenterology and Hepatology, 2023
- Estimated Projection of US Cancer Incidence and Death to 2040JAMA Network Open, 2021
- Screening for Pancreatic CancerJAMA, 2019
- The Harms of ScreeningJAMA Internal Medicine, 2014